Systemic but not intraocular Epo Gene Transfer Protects the Retina from Light-and Genetic-Induced Degeneration
Tonia S. Rex(Vanderbilt University Medical Center), Alberto Auricchio(Federico II University Hospital), Mariacarmela Allocca(Center for Environmental Health), Arkady Lyubarsky(Penn Presbyterian Medical Center), Alessandro Cellerino(Scuola Normale Superiore), Jean Bennett(Penn Presbyterian Medical Center), Albert M. Maguire(Children's Hospital of Philadelphia), Enrico Maria Surace(Telethon Institute Of Genetics And Medicine), Luciano Domenici(Neuroscience Institute)
Cited by 100
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
|Molecular Therapy|2009|551